Advertisement

Revista de Oncología

, Volume 6, Issue 6, pp 372–373 | Cite as

Quimioterapia complementaria tras una metastasectomía

  • José Manual López Vega
Artículo Especial
  • 24 Downloads

Bibliografía

  1. 1.
    Gebauer G, Fehm T, Merkle E, Jaeger W, Mitze M. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients: prognostic relevance after 10 years. Anticancer Res 2003;23:4319–24.PubMedGoogle Scholar
  2. 2.
    Khanna C, Khan J, Nguyen P, et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001;61:3750–9.PubMedGoogle Scholar
  3. 3.
    Kalikin LM, Schneider A, Thakur MA, et al.In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice. Cancer Biol Ther 2003;2:656–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Gradishar WJ, O'Regan RM. Progress in systemic adjuvant therapy of early-stage breast cancer. Int J Clin Oncol 2003;8:239–47.CrossRefPubMedGoogle Scholar
  5. 5.
    Macdonald JS, Astrow AB. Adjuvant therapy of colon cancer. Semin Oncol 2001;28:30–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Frustaci S, De Paoli A, Bidoli E, et al. Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 2003;65(Suppl 2):80–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 2003;95:1453–61 (comentario en p. 1422–4).CrossRefPubMedGoogle Scholar
  8. 8.
    Leong T, Michael M, Foo K, et al. Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation. Br J Cancer 2003;89: 1433–8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Cavallari A, Vivarelli M, Bellusci R, et al. Liver metastases from colorectal cancer: present surgical approach. Hepato-Gastroenterol 2003;50:2067–71.Google Scholar
  10. 10.
    Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J Clin Oncol 2002; 20:3470–7 (comentarios en J Clin Oncol 2003;21:177–8).CrossRefPubMedGoogle Scholar
  11. 11.
    Moazami N, Rice TW, Rybicki LA, et al. Stage III non-small cell lung cancer and metachronous brain metastases. J Thorac Cardiovasc Surg 2002;124:113–22.CrossRefPubMedGoogle Scholar
  12. 12.
    Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 2002;22:335–44.CrossRefPubMedGoogle Scholar
  13. 13.
    Elias D, Maisonnette F, Druet-Cabanac M, et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003;185: 158–64.CrossRefPubMedGoogle Scholar
  14. 14.
    Liu D, Abolhoda A, Burt ME, et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 1998;66:1709–14.CrossRefPubMedGoogle Scholar
  15. 15.
    Onaitis M, Morse M, Hurwitz H, et al. Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 2003; 237:782–9.PubMedPubMedCentralGoogle Scholar

Copyright information

© FESEO 2004

Authors and Affiliations

  • José Manual López Vega
    • 1
  1. 1.Servicio de Oncología MédicaHospital Universitario Marqués de ValdecillaSantanderEspaña

Personalised recommendations